Search
Now showing items 1-1 of 1
Pharmacological and molecular approaches for the treatment of β- hemoglobin disorders
(Wiley, 2017)
β-hemoglobin disorders, such as β-thalassemia and sickle cell anemia are among the most prevalent inherited genetic disorders worldwide. These disorders are caused by mutations in the gene encoding hemoglobin-β (HBB), a ...